MAPT and Alzheimer disease: Furthermore, RNS60 treatment reduced neuronal apoptosis, Tau phosphorylation, glial activation, and Aβ load in vivo in the hippocampus and protected memory and learning in 5XFAD transgenic mouse model of AD.